On September 14, the CMDE (Center for Medical Device Evaluation) announced an updated list of class III medical devices requiring clinical trials replacing the list last released in 2014.
The 2020 amended edition added heart stents and internal fixation devices to the list of devices requiring clinical trials in China with effect from September 14 onwards.
By Jacky Li. Contact Cisema if you would like to learn more.
